Entrada Therapeutics Files 8-K
Ticker: TRDA · Form: 8-K · Filed: Mar 24, 2025 · CIK: 1689375
| Field | Detail |
|---|---|
| Company | Entrada Therapeutics, Inc. (TRDA) |
| Form Type | 8-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Entrada Therapeutics filed a standard 8-K on 3/24/25, no major news.
AI Summary
Entrada Therapeutics, Inc. filed an 8-K on March 24, 2025, reporting on other events and financial statements. The company, formerly known as CycloPorters, Inc. until November 4, 2016, is incorporated in Delaware and headquartered in Boston, MA. The filing does not disclose specific financial figures or material events beyond its routine reporting nature.
Why It Matters
This 8-K filing from Entrada Therapeutics is a routine disclosure, indicating no immediate material changes or significant events to report to investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K and does not contain information about material events, acquisitions, or financial distress.
Key Players & Entities
- Entrada Therapeutics, Inc. (company) — Registrant
- CycloPorters, Inc. (company) — Former company name
- March 24, 2025 (date) — Date of report
- Boston, MA (location) — Principal executive offices
- Delaware (location) — State of incorporation
FAQ
What is the primary purpose of this 8-K filing for Entrada Therapeutics?
This 8-K filing serves as a current report for Entrada Therapeutics, Inc., covering items such as Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 24, 2025.
What was Entrada Therapeutics, Inc. formerly known as?
Entrada Therapeutics, Inc. was formerly known as CycloPorters, Inc.
On what date did the company change its name from CycloPorters, Inc.?
The company changed its name from CycloPorters, Inc. on November 4, 2016.
Where are Entrada Therapeutics, Inc.'s principal executive offices located?
Entrada Therapeutics, Inc.'s principal executive offices are located at One Design Center Place, Suite 17-500, Boston, MA 02210.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 24, 2025 regarding Entrada Therapeutics, Inc. (TRDA).